BANK OF AMERICA CORP /DE/ - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 151 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,234,712
-31.0%
123,967
-22.2%
0.00%
-100.0%
Q2 2023$6,135,977
+27.8%
159,376
+18.8%
0.00%
Q1 2023$4,799,833
+37.2%
134,111
+51.1%
0.00%
Q4 2022$3,499,334
+259.3%
88,748
+228.8%
0.00%
Q3 2022$974,000
-12.6%
26,995
-26.4%
0.00%
Q2 2022$1,115,000
+480.7%
36,655
+483.8%
0.00%
Q1 2022$192,000
-85.6%
6,279
-85.3%
0.00%
Q4 2021$1,337,000
+507.7%
42,798
+197.5%
0.00%
Q3 2021$220,000
+69.2%
14,387
+106.1%
0.00%
Q2 2021$130,000
-57.9%
6,979
-59.6%
0.00%
Q1 2021$309,000
+602.3%
17,272
+504.3%
0.00%
Q4 2020$44,000
+18.9%
2,858
-14.5%
0.00%
Q3 2020$37,000
-15.9%
3,343
-5.3%
0.00%
Q2 2020$44,000
+29.4%
3,530
+34.8%
0.00%
Q4 2019$34,0002,618
+4839.6%
0.00%
Q2 2019$0
-100.0%
53
-35.4%
0.00%
Q1 2019$1,000
-87.5%
82
-93.8%
0.00%
Q4 2018$8,000
-55.6%
1,329
-39.1%
0.00%
Q3 2015$18,000
-64.7%
2,182
-28.1%
0.00%
Q1 2015$51,000
-15.0%
3,0330.0%0.00%
Q4 2014$60,0003,0330.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders